Abiopharma

Croom Lawrence Joins Hemostemix with Revenue Share Agreement and VesCell.Health Launch

NanoVibronix Inc Notification (NAOV)

Deadline Alert: Rocket Pharmaceuticals, Inc. (RCKT) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Fortrea Holdings Inc. (FTRE) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

Everything Coming to Acorn TV in July 2025

Everything Coming to Apple TV+ in July 2025

FDA approve CARBON DIOXIDE

Everything Coming to Hulu in July 2025

Everything Coming to AMC+ in July 2025

Best Air Purifiers for Allergy Sufferers in 2025

New Form 8-K - Lyra Therapeutics, Inc. Filed: 2025-06-27 AccNo: 0001193125-25-150301 Size: 685 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

FDA approve ENZALUTAMIDE

FDA approve BICTEGRAVIR, EMTRICITABINE AND TENOFOVIR ALAFENAMIDE

FDA approve OCTREOTIDE

FDA approve ZINC SULFATE HEPTAHYDRATE, CUPRIC SULFATE, MANGANESE SULFATE, SELENIOUS ACID